EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of a potent and selective LAPTc inhibitor by RapidFire-Mass Spectrometry, with antichagasic activity

Maikel Izquierdo, De Lin, Sandra O'Neill, Lauren A Webster, Christy Paterson, John Thomas, Mirtha Elisa Aguado, Enrique Colina Araújo, Daniel Alpízar-Pedraza, Halimatu Joji, Lorna MacLean, Anthony Hope und 5 weitere

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0011956 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Maikel Izquierdo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Protein Studies, Faculty of Biology, University of Havana, La Habana, Cuba. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Chagas Disease, Trypanocidal Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Chagas disease is caused by the protozoan parasite Trypanosoma cruzi and leads to ~10,000 deaths each year. Nifurtimox and benznidazole are the only two drugs available but have significant adverse effects and limited efficacy. New chemotherapeutic agents are urgently required. Here we identified inhibitors of the acidic M17 leucyl-aminopeptidase from T . cruzi (LAPTc) that show promise as novel starting points for Chagas disease drug discovery. Methodology/Principal findings A RapidFire-MS screen with a protease-focused compound library identified novel LAPTc inhibitors. Twenty-eight hits were progressed to the dose-response studies, from which 12 molecules inhibited LAPTc with IC 50 < 34 μM. Of these, compound 4 was the most potent hit and mode of inhibition studies indicate that compound 4 is a competitive LAPTc inhibitor, with K i 0.27 μM. Compound 4 is selective with respect to human LAP3, showing a selectivity index of >500. Compound 4 exhibited sub-micromolar activity against intracellular T . cruzi amastigotes, and while the selectivity-window against the host cells was narrow, no toxicity was observed for un-infected HepG2 cells. In silico modelling of the LAPTc-compound 4 interaction is consistent with the competitive mode of inhibition. Molecular dynamics simulations reproduce the experimental binding strength (-8.95 kcal/mol), and indicate a binding mode based mainly on hydrophobic interactions with active site residues without metal cation coordination. Conclusions/Significance Our data indicates that these new LAPTc inhibitors should be considered for further development as antiparasitic agents for the treatment of Chagas disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypanosoma cruziChagas DiseaseTrypanocidal AgentsHumansLeucyl AminopeptidaseDrug DiscoveryAntiparasitic Agents

Substanzen

Leucyl AminopeptidaseAntiparasitic AgentsTrypanocidal Agents

Autor:innen und Institutionen

  • Centre for Protein Studies, Faculty of Biology, University of Havana, La Habana, Cuba.
  • Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, United Kingdom.
  • Department of Biochemistry, Faculty of Biology, University of Havana, La Habana, Cuba.
  • Centre for Pharmaceuticals Research and Development, La Habana, Cuba.
  • Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
  • Department of Parasitology, Faculty of Science, Charles University in Prague, Biocev, Vestec, Czech Republic.

ORCID-Profile: Manu De Rycker

Förderung

  • Wellcome Trust

Zitieren

APA

Izquierdo, M., Lin, O'Neill, S., Webster, L. A., Paterson, C., Thomas, J., Aguado, M. E., Colina Araújo, E., Alpízar-Pedraza, D., Joji, H., MacLean, L., Hope, A., Gray, D. W., Zoltner, M., Field, M. C., González-Bacerio, J., & De Rycker, M. (2024). Identification of a potent and selective LAPTc inhibitor by RapidFire-Mass Spectrometry, with antichagasic activity. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011956

Vancouver

Izquierdo M, Lin, O'Neill S, Webster LA, Paterson C, Thomas J, et al. Identification of a potent and selective LAPTc inhibitor by RapidFire-Mass Spectrometry, with antichagasic activity. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0011956

BibTeX
@article{Izquierdo2024,
  author = {Izquierdo, Maikel and Lin, De and O'Neill, Sandra and Webster, Lauren A and Paterson, Christy and Thomas, John and Aguado, Mirtha Elisa and Colina Araújo, Enrique and Alpízar-Pedraza, Daniel and Joji, Halimatu and MacLean, Lorna and Hope, Anthony and Gray, David W and Zoltner, Martin and Field, Mark C and González-Bacerio, Jorge and De Rycker, Manu},
  title = {Identification of a potent and selective LAPTc inhibitor by RapidFire-Mass Spectrometry, with antichagasic activity},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0011956}
}
Kostenlos starten →